Screener
Acadia Pharmaceuticals ACAD Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Acadia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Acadia Pharmaceuticals’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333243
FAQ
- What is Acadia Pharmaceuticals's total assets?
- Acadia Pharmaceuticals (ACAD) reported total assets of $1.74B in Q2 2026.
- How has Acadia Pharmaceuticals's total assets changed year-over-year?
- Acadia Pharmaceuticals's total assets increased by 42.2% year-over-year, from $1.23B to $1.74B.
- What is the long-term trend for Acadia Pharmaceuticals's total assets?
- Over 5 years (2020 to 2025), Acadia Pharmaceuticals's total assets has grown at a 14.9% compound annual growth rate (CAGR), from $782.62M to $1.56B.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Acadia Pharmaceuticals's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude